LifeStance Health Group, Inc. (LFST) Revenue, Earnings & Financial Statements
$14.17NASDAQ: LFSTMarket Cap $5.39B
Data as of Nov 17, 2026 close · Statements through the quarter ended Sep 2026 · Source: Financial Modeling Prep (methodology)
LifeStance Health Group, Inc. most recently reported annual revenue of $1.4B, net profit of $10.0M. Revenue grew at an average annual rate of 30.4% over the last 5 fiscal years. See the full income statement, balance sheet, and cash flow statement below, plus valuation and return ratios.
LifeStance Health Group, Inc.: Revenue rose from $213.0M in 2019 to $1.4B in 2025, a change of +568.5% over 6 years; net profit was positive in 2 of 7 reported years; operating margin moved from 7.2% to 1.7%, a shift of -5.5 percentage points; the most recent year shows net profit of $10.0M.
Income Statement — 7 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
2025
Revenue
$213.0M
$377.0M
$668.0M
$860.0M
$1.1B
$1.3B
$1.4B
Operating Expenses
$197.0M
$362.0M
$954.0M
$1.1B
$1.2B
$1.3B
$1.4B
Operating Profit
$15.0M
$15.0M
−$286.0M
−$210.0M
−$189.0M
−$32.0M
$24.0M
Operating Margin
7.2%
4.1%
-42.9%
-24.4%
-17.9%
-2.5%
1.7%
Other Income
−$7.0M
−$60.0M
−$47.0M
−$23.0M
−$17.0M
−$26.0M
−$12.0M
Interest
$5.0M
$22.0M
$39.0M
$20.0M
$21.0M
$27.0M
$12.0M
Depreciation
$6.0M
$31.0M
$54.0M
$69.0M
$80.0M
$71.0M
$55.0M
Profit Before Tax
$8.0M
−$44.0M
−$333.0M
−$233.0M
−$207.0M
−$58.0M
$12.0M
Tax rate (%)
28.0%
14.3%
7.8%
7.4%
9.8%
0.3%
21.8%
Net Profit
$6.0M
−$38.0M
−$307.0M
−$216.0M
−$186.0M
−$57.0M
$10.0M
EPS
−$0.16
−$0.83
−$1.05
−$0.61
−$0.51
−$0.15
$0.02
Quarterly Results — Last 12 Quarters (USD millions)
8 duplicate period labels in the source data were collapsed.
Metric
Dec '23
Mar '24
Jun '24
Sep '24
Dec '24
Mar '25
Jun '25
Sep '25
Dec '25
Mar '26
Jun '26
Sep '26
Revenue
$281.0M
$300.0M
$312.0M
$313.0M
$325.0M
$333.0M
$345.0M
$364.0M
$382.0M
$403.0M
$435.0M
$456.0M
Operating Expenses
$313.0M
$317.0M
$328.0M
$313.0M
$324.0M
$331.0M
$348.0M
$356.0M
$364.0M
$381.0M
$405.0M
$423.0M
Operating Profit
−$32.0M
−$17.0M
−$16.0M
$0
$1.0M
$2.0M
−$3.0M
$7.0M
$18.0M
$22.0M
$31.0M
$33.0M
Operating Margin
-11.5%
-5.6%
-5.1%
0.0%
0.3%
0.5%
-0.8%
2.0%
4.7%
5.5%
7.0%
7.3%
Interest
$6.0M
$6.0M
$6.0M
$5.0M
$9.0M
$3.0M
$3.0M
$3.0M
$3.0M
$2.0M
$3.0M
$2.0M
Profit Before Tax
−$38.0M
−$21.0M
−$23.0M
−$5.0M
−$9.0M
−$1.0M
−$6.0M
$5.0M
$15.0M
$20.0M
$27.0M
$27.0M
Tax rate (%)
-17.3%
-1.8%
-2.9%
-10.7%
19.9%
148.2%
36.2%
76.4%
23.3%
27.9%
14.0%
18.3%
Net Profit
−$45.0M
−$21.0M
−$23.0M
−$6.0M
−$7.0M
$1.0M
−$4.0M
$1.0M
$12.0M
$14.0M
$24.0M
$22.0M
EPS
−$0.12
−$0.06
−$0.06
−$0.02
−$0.02
$0.00
−$0.01
$0.00
$0.03
$0.04
$0.06
$0.06
Over the 7 years reported for LifeStance Health Group, Inc., borrowings increased from $79.0M in 2019 to $194.0M in 2025, cash stood at $249.0M in the latest year, shareholders' equity was $4.0M, current assets covered current liabilities 1.65 times.
Balance Sheet — 7 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
2025
Total Assets
$281.0M
$1.6B
$1.9B
$2.2B
$2.1B
$2.1B
$2.2B
Current Assets
$27.0M
$76.0M
$267.0M
$233.0M
$226.0M
$313.0M
$416.0M
Cash
$3.0M
$19.0M
$148.0M
$109.0M
$79.0M
$155.0M
$249.0M
Inventory
$0
$0
$38.0M
$0
$0
$0
$0
Receivables
$19.0M
$44.0M
$99.0M
$102.0M
$126.0M
$132.0M
$96.0M
Fixed Assets
$22.0M
$59.0M
$152.0M
$394.0M
$359.0M
$314.0M
$311.0M
Capital Work in Progress
$0
$0
$0
$0
$0
$0
$0
Investments
$0
−$11.0M
−$43.0M
$0
$0
$0
$0
Other Assets
$215.0M
$1.1B
$1.2B
$1.3B
$1.3B
$1.3B
$1.3B
Total Liabilities
$447.0M
$572.0M
$382.0M
$655.0M
$681.0M
$672.0M
$683.0M
Current Liabilities
$55.0M
$76.0M
$117.0M
$176.0M
$203.0M
$229.0M
$252.0M
Borrowings
$79.0M
$366.0M
$159.0M
$479.0M
$511.0M
$485.0M
$194.0M
Other Liabilities
$368.0M
$206.0M
$223.0M
$176.0M
$170.0M
$187.0M
$489.0M
Equity
$0
$1.0B
$4.0M
$4.0M
$4.0M
$4.0M
$4.0M
Reserves
−$166.0M
$998.0M
$1.5B
$1.5B
$1.4B
$1.4B
$1.5B
For LifeStance Health Group, Inc., operating cash flow was positive in 5 of 7 reported years; free cash flow in the latest year was $110.0M; free cash flow was positive in 3 of 7 years; financing activities used $9.0M in the latest year, which covers debt repayment, dividends and buybacks.
Cash Flow Statement — 7 Years (USD millions)
Metric
2019
2020
2021
2022
2023
2024
2025
Operating Cash Flow
$17.0M
−$9.0M
$9.0M
$53.0M
−$17.0M
$107.0M
$146.0M
Investing Cash Flow
−$88.0M
−$899.0M
−$289.0M
−$219.0M
−$101.0M
−$43.0M
−$72.0M
Financing Cash Flow
−$7.0M
$600.0M
−$12.0M
−$22.0M
−$8.0M
−$8.0M
−$9.0M
Net Cash Flow
−$8.0M
$15.0M
$129.0M
−$39.0M
−$30.0M
$76.0M
$94.0M
Free Cash Flow
$3.0M
−$47.0M
−$85.0M
−$26.0M
−$57.0M
$86.0M
$110.0M
Valuation & Return Ratios
Metric
Value
PEG Ratio
0.03
EV / EBITDA
36.68
FCF Yield
3.28%
Quick Ratio
1.44
Interest Coverage
10.63
Return 1Y
123.14%
Return 3Y
126.73%
Return 5Y
38.97%
LifeStance Health Group, Inc. (LFST) financials — frequently asked questions
What is LifeStance Health Group, Inc.'s annual revenue?
LifeStance Health Group, Inc. (LFST) reported annual revenue of $1.4B in its most recent fiscal year.
What is LifeStance Health Group, Inc.'s net profit?
LifeStance Health Group, Inc. (LFST) reported net profit of $10.0M in its most recent fiscal year.
What is LFST EV/EBITDA?
LifeStance Health Group, Inc.'s enterprise value to EBITDA (EV/EBITDA) ratio is 36.68.
Revenue and earnings of other Medical - Care Facilities stocks